Soni Medicare [SML] vs Shalby [SHALBY] Detailed Stock Comparison

Soni Medicare

Shalby
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Soni Medicare wins in 10 metrics, Shalby wins in 8 metrics, with 0 ties. Soni Medicare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Soni Medicare | Shalby | Better |
---|---|---|---|
P/E Ratio (TTM) | 103.13 | 1,122.67 | Soni Medicare |
Price-to-Book Ratio | 18.21 | 2.16 | Shalby |
Debt-to-Equity Ratio | 810.21 | 47.82 | Shalby |
PEG Ratio | -1.55 | -23.30 | Shalby |
EV/EBITDA | 25.63 | 23.04 | Shalby |
Profit Margin (TTM) | 1.24% | -0.05% | Soni Medicare |
Operating Margin (TTM) | -0.54% | 8.44% | Shalby |
EBITDA Margin (TTM) | N/A | 8.44% | N/A |
Return on Equity | -14.25% | 0.63% | Shalby |
Return on Assets (TTM) | -0.84% | 0.37% | Shalby |
Free Cash Flow (TTM) | $8.76M | $-757.89M | Soni Medicare |
Dividend Yield | N/A | 0.65% | N/A |
1-Year Return | 215.85% | -18.18% | Soni Medicare |
Price-to-Sales Ratio (TTM) | 1.27 | 2.13 | Soni Medicare |
Enterprise Value | $486.72M | $31.07B | Shalby |
EV/Revenue Ratio | 1.55 | 2.81 | Soni Medicare |
Gross Profit Margin (TTM) | 72.61% | 39.66% | Soni Medicare |
Revenue per Share (TTM) | $125 | $88 | Soni Medicare |
Earnings per Share (Diluted) | $0.91 | $-0.48 | Soni Medicare |
Beta (Stock Volatility) | -0.36 | 0.44 | Soni Medicare |
Soni Medicare vs Shalby Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Soni Medicare | 2.00% | 10.38% | 71.31% | 84.63% | 186.73% | 185.05% |
Shalby | -1.27% | 16.95% | 14.07% | 25.68% | 14.02% | 0.10% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Soni Medicare | 215.85% | 221.15% | 169.70% | 509.81% | 509.81% | 509.81% |
Shalby | -18.18% | 72.72% | 185.98% | -3.44% | -3.44% | -3.44% |
News Based Sentiment: Soni Medicare vs Shalby
Soni Medicare
News based Sentiment: MIXED
Soni Medicare experienced significant positive momentum with a new all-time high stock price and strong returns, but concerns remain regarding its negative ROE and a slight decline in recent revenue. This creates a mixed investment picture, balancing strong growth with underlying financial challenges.
Shalby
News based Sentiment: MIXED
Shalby Ltd. reported strong Q3 FY2025 results with significant revenue growth, but faces mixed analyst sentiment regarding its valuation and future growth potential. The company is actively engaging with investors, indicating a focus on transparency and future development.
Performance & Financial Health Analysis: Soni Medicare vs Shalby
Metric | SML | SHALBY |
---|---|---|
Market Information | ||
Market Cap | ₹410.23M | ₹23.55B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 2,031 | 1,413,879 |
90 Day Avg. Volume | 1,199 | 643,540 |
Last Close | ₹97.63 | ₹231.36 |
52 Week Range | ₹29.50 - ₹97.63 | ₹177.25 - ₹297.90 |
% from 52W High | 0.00% | -22.34% |
All-Time High | ₹97.63 (Sep 09, 2025) | ₹339.50 (Jan 22, 2024) |
% from All-Time High | 0.00% | -31.85% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.03% | 0.06% |
Quarterly Earnings Growth | 0.03% | -0.46% |
Financial Health | ||
Profit Margin (TTM) | 0.01% | 0.00% |
Operating Margin (TTM) | -0.01% | 0.08% |
Return on Equity (TTM) | -0.14% | 0.01% |
Debt to Equity (MRQ) | 810.21 | 47.82 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹5.16 | ₹101.79 |
Cash per Share (MRQ) | ₹4.70 | ₹10.31 |
Operating Cash Flow (TTM) | ₹-10,088,000 | ₹-417,020,000 |
Levered Free Cash Flow (TTM) | ₹-1,864,000 | ₹62.22M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | 0.65% |
Last 12-Month Dividend | N/A | ₹1.20 |
Valuation & Enterprise Metrics Analysis: Soni Medicare vs Shalby
Metric | SML | SHALBY |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 103.13 | 1,122.67 |
Forward P/E | N/A | 23.35 |
PEG Ratio | -1.55 | -23.30 |
Price to Sales (TTM) | 1.27 | 2.13 |
Price to Book (MRQ) | 18.21 | 2.16 |
Market Capitalization | ||
Market Capitalization | ₹410.23M | ₹23.55B |
Enterprise Value | ₹486.72M | ₹31.07B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.55 | 2.81 |
Enterprise to EBITDA | 25.63 | 23.04 |
Risk & Other Metrics | ||
Beta | -0.36 | 0.44 |
Book Value per Share (MRQ) | ₹5.16 | ₹101.79 |
Financial Statements Comparison: Soni Medicare vs Shalby
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | SML | SHALBY |
---|---|---|
Revenue/Sales | ₹72.77M | ₹2.96B |
Cost of Goods Sold | ₹19.93M | ₹1.79B |
Gross Profit | ₹52.84M | ₹1.18B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹-402,000 | ₹250.15M |
EBITDA | ₹897,000 | ₹485.47M |
Pre-Tax Income | ₹-2.94M | ₹226.53M |
Income Tax | ₹-50,000 | ₹149.75M |
Net Income (Profit) | ₹-2.91M | ₹76.78M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | SML | SHALBY |
---|---|---|
Cash & Equivalents | ₹20.10M | ₹347.85M |
Total Current Assets | ₹137.75M | ₹6.58B |
Total Current Liabilities | ₹103.85M | ₹4.55B |
Long-Term Debt | ₹94.12M | ₹1.75B |
Total Shareholders Equity | ₹13.08M | ₹9.95B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹60.31M | ₹8.88B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | SML | SHALBY |
---|---|---|
Operating Cash Flow | N/A | ₹433.19M |
Capital Expenditures | N/A | ₹-563.59M |
Free Cash Flow | N/A | ₹-66.61M |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | SML | SHALBY |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 2,031 | 1,413,879 |
Average Daily Volume (90 Day) | 1,199 | 643,540 |
Shares Outstanding | 4.26M | 107.27M |
Float Shares | 705,803 | 31.05M |
% Held by Insiders | 0.83% | 0.77% |
% Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Soni Medicare vs Shalby
Metric | SML | SHALBY |
---|---|---|
Last 12-Month Dividend | N/A | ₹1.20 |
Last 12-Month Dividend Yield | N/A | 0.65% |
3-Year Avg Annual Dividend | N/A | ₹1.08 |
3-Year Avg Dividend Yield | N/A | 0.55% |
3-Year Total Dividends | N/A | ₹3.23 |
Ex-Dividend Date | N/A | Sep 19, 2024 |